[Without short acting insulin analogs. Is therapy quality really maintained? (interview by Dirk Einecke)].
作者信息
Lüddeke Hans J
出版信息
MMW Fortschr Med. 2006 Sep 14;148(37):9.
PMID:17036893
Abstract
摘要
相似文献
1
[Without short acting insulin analogs. Is therapy quality really maintained? (interview by Dirk Einecke)].
MMW Fortschr Med. 2006 Sep 14;148(37):9.
2
More from PHARMAC on long-acting insulin analogues: insulin glargine now funded.更多来自药物治疗咨询委员会关于长效胰岛素类似物的信息：甘精胰岛素现已纳入医保。
N Z Med J. 2006 Jun 23;119(1236):U2040.
3
[Will prescribing all types of insulin no longer be allowed?].[是否将不再允许开具所有类型的胰岛素处方？]
MMW Fortschr Med. 2006 Mar 9;148(10):44-6.
4
[Economics under scrutiny - experts discuss long acting insulin analogs].[经济学受审视——专家探讨长效胰岛素类似物]
Pflege Z. 2011 Jan;64(1):58.
5
[Comment on IOWiG report plan. A medical decision may not be replaced].[关于IOWiG报告计划的评论。医疗决策不可替代]
MMW Fortschr Med. 2006 May 11;148(19):42.
6
[The new drug cost saving package. Sensible measures or risk for patients?].[新药成本节约方案。合理措施还是患者风险？]
Krankenpfl J. 2002;40(5-6):159.
7
[Current cost analysis in the management of diabetes mellitus].[糖尿病管理中的当前成本分析]
Dtsch Med Wochenschr. 2008 Aug;133 Suppl 4:S110-4; discussion S124-6. doi: 10.1055/s-2008-1081104.
8
[How many diabetic patients in your practice? Important references for regress defense].
MMW Fortschr Med. 2005 Oct 6;147(40):48-9.
9
PHARMAC responds on long-acting insulin analogues.药物治疗咨询委员会对长效胰岛素类似物作出回应。
N Z Med J. 2005 Oct 28;118(1224):U1716.
10
[Insulin therapy in type 2 diabetes. Insured patients would be willing to pay for added benefits].[2型糖尿病的胰岛素治疗。参保患者愿意为额外福利付费]
MMW Fortschr Med. 2008 Dec 4;150(49-50):56-7.
Zotero 插件